Company
Headquarters: Clearwater, FL, United States
CEO: Dr. M. Kevin Sorrels D.D.S.
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $201.46 B |
| EssilorLuxottica SA | $144.43 B |
| Becton, Dickinson and Company | $55.63 B |
| HOYA Corp | $50.63 B |
| Alcon Inc. | $39.46 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Golden Valley Development, Inc, through its subsidiaries, manufactures and markets patented products in the health care and home consumer markets sectors. Its products include Percuguard and Cutstop used as finger guards which protect finger and thumbs from accidental cuts from knives and other sharp implements. The company is also engaged in the media consultancy practice wherein entertainment and sports industry companies, investors, personalities, and other figures are identified and brought to participate in joint venture marketing and entertainment projects being developed. Golden Valley Development, Inc was founded in 2004 and is based in Clearwater, Florida.
Golden Valley Development, Inc. has the following listings and related stock indices.
Stock: OTC: GVDI